Development of Core Educational Content for Heart Failure Patients in Transition from Hospital to Home Care: A Delphi Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Participants
2.3. Research Procedure and Data Collection
2.3.1. Development of Research Drafts
2.3.2. Delphi Survey
2.4. Data Analysis
2.5. Ethical Considerations
3. Results
3.1. Demographics of the Panel Experts
3.2. Results of Round 1
3.3. Results of Rounds 2 and 3
4. Discussion
Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Wang, H.; Chai, K.; Du, M.; Wang, S.; Cai, J.P.; Li, Y.; Zeng, P.; Zhu, W.; Zhan, S.; Yang, J. Prevalence and incidence of heart failure among urban patients in china: A national population-based analysis. Circ. Heart Fail. 2021, 14, e008406. [Google Scholar] [CrossRef]
- Ødegaard, K.M.; Hallén, J.; Lirhus, S.S.; Melberg, H.O.; Halvorsen, S. Incidence, prevalence, and mortality of heart failure: A nationwide registry study from 2013 to 2016. ESC Heart Fail. 2020, 7, 1917–1926. [Google Scholar] [CrossRef]
- Agarwal, M.A.; Fonarow, G.C.; Ziaeian, B. National trends in heart failure hospitalizations and readmissions from 2010 to 2017. JAMA Cardiol. 2021, 6, 952–956. [Google Scholar] [CrossRef] [PubMed]
- Lee, J.H.; Lim, N.K.; Cho, M.C.; Park, H.Y. Epidemiology of heart failure in Korea: Present and future. Korean Circ. J. 2016, 46, 658–664. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wideqvist, M.; Cui, X.; Magnusson, C.; Schaufelberger, M.; Fu, M. Hospital readmissions of patients with heart failure from real world: Timing and associated risk factors. ESC Heart Fail. 2021, 8, 1388–1397. [Google Scholar] [CrossRef] [PubMed]
- Khan, M.S.; Sreenivasan, J.; Lateef, N.; Abougergi, M.S.; Greene, S.J.; Ahmad, T.; Anker, S.D.; Fonarow, G.C.; Butler, J. Trends in 30- and 90-day readmission rates for heart failure. Circ. Heart Fail. 2021, 14, e008335. [Google Scholar] [CrossRef] [PubMed]
- Shim, J.L.; Hwang, S.Y. Development and effects of a heart health diary for self-care enhancement of patients with heart failure. J. Korean Acad. Nurs. 2016, 46, 881–893. [Google Scholar] [CrossRef] [PubMed]
- Sevilla-Cazes, J.; Ahmad, F.S.; Bowles, K.H.; Jaskowiak, A.; Gallagher, T.; Goldberg, L.R.; Kangovi, S.; Alexander, M.; Riegel, B.; Barg, F.K.; et al. Heart failure home management challenges and reasons for readmission: A qualitative study to understand the patient’s perspective. J. Gen. Intern. Med. 2018, 33, 1700–1707. [Google Scholar] [CrossRef] [Green Version]
- Hu, X.; Dolansky, M.A.; Su, Y.; Hu, X.; Qu, M.; Zhou, L. Effect of a multidisciplinary supportive program for family caregivers of patients with heart failure on caregiver burden, quality of life, and depression: A randomized controlled study. Int. J. Nurs. Stud. 2016, 62, 11–21. [Google Scholar] [CrossRef]
- Strömberg, A. The crucial role of patient education in heart failure. Eur. J. Heart Fail. 2005, 7, 363–369. [Google Scholar] [CrossRef]
- Sousa, J.P.; Oliveira, C.; Pais-Vieira, M. Symptom perception management education improves self-care in patients with heart failure. Work 2021, 69, 465–473. [Google Scholar] [CrossRef]
- Yu, M.M.; Chair, S.Y.; Chan, C.W.; Choi, K.C. Information needs of older people with heart failure: Listening to their own voice. J. Geriatr. Cardiol. 2016, 13, 435–438. [Google Scholar] [CrossRef]
- Hasson, F.; Keeney, S.; McKenna, H. Research guidelines for the Delphi survey technique. J. Adv. Nurs. 2000, 32, 1008–1015. [Google Scholar]
- de Villiers, M.R.; de Villiers, P.J.; Kent, A.P. The Delphi technique in health sciences education research. Med. Teach. 2005, 27, 639–643. [Google Scholar] [CrossRef]
- Clayton, M.J. Delphi: A technique to harness expert opinion for critical decision-making tasks in education. Edu. Psychol. 1997, 17, 373–386. [Google Scholar] [CrossRef]
- Adler, M.; Ziglio, E. Gazing into the Oracle: The Delphi and Its Application to Social Policy and Public Health; Ziglio, E., Ed.; Jessica Kingsley: London, UK, 1996; p. 268. [Google Scholar]
- Hsu, C.C.; Sandford, B.A. The Delphi technique: Making sense of consensus. practical assessment, research and evaluation. Pract. Assess. Res. Eval. 2007, 12, 10. [Google Scholar] [CrossRef]
- Noh, S.Y. Delphi technique: Forecasting the future with professional insight. Plan. Policy 2006, 299, 53–62. [Google Scholar]
- Ponikowski, P.; Voors, A.A.; Anker, S.D.; Bueno, H.; Cleland, J.G.; Coats, A.J.; Falk, V.; González-Juanatey, J.R.; Harjola, V.P.; Jankowska, E.A.; et al. ESC Scientific Document Group. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). developed with the special contribution of the heart failure association (HFA) of the ESC. Eur. J. Heart Fail. 2016, 18, 891–975. [Google Scholar] [CrossRef]
- Seferovic, P.M.; Ponikowski, P.; Anker, S.D.; Bauersachs, J.; Chioncel, O.; Cleland, J.; de Boer, R.A.; Drexel, H.; Ben Gal, T.; Hill, L.; et al. Clinical practice update on heart failure 2019: Pharmacotherapy, procedures, devices and patient management. an expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2019, 21, 1169–1186. [Google Scholar] [CrossRef]
- Yancy, C.W.; Jessup, M.; Bozkurt, B.; Butler, J.; Casey, D.E.; Drazner, M.H., Jr.; Fonarow, G.C.; Geraci, S.A.; Horwich, T.; Januzzi, J.L.; et al. American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. 2013 ACCF/AHA guideline for the management of heart failure. Circulation 2013, 128, e240–e327. [Google Scholar] [CrossRef]
- Yancy, C.W.; Jessup, M.; Bozkurt, B.; Butler, J.; Casey, D.E.; Colvin, M.M., Jr.; Drazner, M.H.; Filippatos, G.S.; Fonarow, G.C.; Givertz, M.M.; et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America. J. Am. Coll. Cardiol. 2017, 70, 776–803. [Google Scholar] [CrossRef]
- Kim, M.S.; Lee, J.H.; Kim, E.J.; Park, D.G.; Park, S.J.; Park, J.J.; Shin, M.S.; Yoo, B.S.; Youn, J.C.; Lee, S.E.; et al. Korean guidelines for diagnosis and management of chronic heart failure. Korean Circ. J. 2017, 47, 555–643. [Google Scholar] [CrossRef] [Green Version]
- Lee, J.H.; Kim, M.S.; Kim, E.J.; Park, D.G.; Cho, H.J.; Yoo, B.S.; Kang, S.M.; Choi, D.J. KSHF guidelines for the management of acute heart failure: Part I. definition, epidemiology and diagnosis of acute heart failure. Korean Circ. J. 2019, 49, 1–21. [Google Scholar] [CrossRef] [Green Version]
- Lee, J.H.; Kim, M.S.; Yoo, B.S.; Park, S.J.; Park, J.J.; Shin, M.S.; Youn, J.C.; Lee, S.E.; Jang, S.Y.; Choi, S.; et al. KSHF guidelines for the management of acute heart failure: Part II. treatment of acute heart failure. Korean Circ. J. 2019, 49, 22–45. [Google Scholar] [CrossRef]
- Kim, M.S.; Lee, J.H.; Cho, H.J.; Cho, J.Y.; Choi, J.O.; Hwang, K.K.; Yoo, B.S.; Kang, S.M.; Choi, D.J. KSHF guidelines for the management of acute heart failure: Part III. specific management of acute heart failure according to the etiology and co-morbidity. Korean Circ. J. 2019, 49, 46–68. [Google Scholar] [CrossRef]
- Cowie, M.R.; Anker, S.D.; Cleland, J.; Felker, G.M.; Filippatos, G.; Jaarsma, T.; Jourdain, P.; Knight, E.; Massie, B.; Ponikowski, P.; et al. Improving care for patients with acute heart failure: Before, during and after hospitalization. ESC Heart Fail. 2014, 1, 110–145. [Google Scholar] [CrossRef]
- Lawshe, C.H. A quantitative approach to content validity. Pers. Psychol. 1975, 28, 563–575. [Google Scholar] [CrossRef]
- Mattina, K.; Dabney, B.W.; Linton, M. The impact of nurse education on heart failure readmissions and patient education. J. Dr. Nurs. Pract. 2021, JDNP-D-19-00076. [Google Scholar] [CrossRef]
- Hill, C.A. Acute heart failure: Too sick for discharge teaching? Crit. Care Nurs. Q. 2009, 32, 106–111. [Google Scholar] [CrossRef]
- Agency for Healthcare Research and Quality. Strategy 4: Care Transitions from Hospital to Home: IDEAL Discharge Planning Implementation Handbook Gives An Overview of and Rationale for the IDEAL Discharge Planning Strategy and Provides Step-by-Step Guidance to Help Hospitals Put This Strategy into Place and Addresses Common Challenges. 2017. Available online: www.ahrq.gov/patient-safety/patients-families/engagingfamilies/strategy4/index.html (accessed on 20 September 2021).
- Baecker, A.; Meyers, M.; Koyama, S.; Taitano, M.; Watson, H.; Machado, M.; Nguyen, H.Q. Evaluation of a transitional care program after hospitalization for heart failure in an integrated health care system. JAMA Netw. Open 2020, 3, e2027410. [Google Scholar] [CrossRef]
- Li, M.; Li, Y.; Meng, Q.; Li, Y.; Tian, X.; Liu, R.; Fang, J. Effects of nurse-led transitional care interventions for patients with heart failure on healthcare utilization: A meta-analysis of randomized controlled trials. PLoS ONE 2021, 16, e0261300. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.; Fang, J.; Li, M.; Luo, B. Effect of nurse-led hospital-to-home transitional care interventions on mortality and psychosocial outcomes in adults with heart failure: A meta-analysis. Eur. J. Cardiovasc. Nurs. 2021, zvab105. [Google Scholar] [CrossRef] [PubMed]
- Riegel, B.; Dickson, V.V.; Faulkner, K.M. The situation-specific theory of heart failure self-care: Revised and updated. J. Cardiovasc. Nurs. 2016, 31, 226–335. [Google Scholar] [CrossRef] [PubMed]
- Lee, C.S.; Bidwell, J.T.; Paturzo, M.; Alvaro, R.; Cocchieri, A.; Jaarsma, T.; Strömberg, A.; Riegel, B.; Vellone, E. Patterns of self-care and clinical events in a cohort of adults with heart failure: 1 year follow-up. Heart Lung 2018, 47, 40–46. [Google Scholar] [CrossRef]
- Boyde, M.; Peters, R. Education material for heart failure patients: What works and what does not? Curr. Heart Fail. Rep. 2014, 11, 314–320. [Google Scholar] [CrossRef]
- Driscoll, A.; Romaniuk, H.; Dinh, D.; Amerena, J.; Brennan, A.; Hare, D.L.; Kaye, D.; Lefkovits, J.; Lockwood, S.; Neil, C.; et al. Clinical risk prediction model for 30-day all-cause re-hospitalisation or mortality in patients hospitalised with heart failure. Int. J. Cardiol. 2022, 350, 69–76. [Google Scholar] [CrossRef]
- Wells, R.; Dionne-Odom, J.N.; Azuero, A.; Buck, H.; Ejem, D.; Burgio, K.L.; Stockdill, M.L.; Tucker, R.; Pamboukian, S.V.; Tallaj, J.; et al. Examining adherence and dose effect of an early palliative care intervention for advanced heart failure patients. J. Pain Symptom Manag. 2021, 62, 471–481. [Google Scholar] [CrossRef]
- Ivynian, S.E.; Newton, P.J.; DiGiacomo, M. Patient preferences for heart failure education and perceptions of patient-provider communication. Scand J. Caring Sci. 2020, 34, 1094–1101. [Google Scholar] [CrossRef]
- Andrews, A.M.; Russell, C.L.; Cheng, A.L. Medication adherence interventions for older adults with heart failure: A systematic review. J. Gerontol. Nurs. 2017, 43, 37–45. [Google Scholar] [CrossRef] [Green Version]
- Bos-Touwen, I.; Jonkman, N.; Westland, H.; Schuurmans, M.; Rutten, F.; de Wit, N.; Trappenburg, J. Tailoring of self-management interventions in patients with heart failure. Curr. Heart Fail. Rep. 2015, 12, 223–235. [Google Scholar] [CrossRef] [Green Version]
- Driscoll, A.; Davidson, P.; Clark, R.; Huang, N.; Aho, Z. Tailoring consumer resources to enhance self-care in chronic heart failure. Aust. Crit. Care 2009, 22, 133–140. [Google Scholar] [CrossRef] [Green Version]
- Davisson, E.; Swanson, E. Nurses’ heart failure discharge planning part II: Implications for the hospital system. Appl. Nurs. Res. 2020, 56, 151336. [Google Scholar] [CrossRef]
- Bennett, S.J.; Lane, K.A.; Welch, J.; Perkins, S.M.; Brater, D.C.; Murray, M.D. Medication and dietary compliance beliefs in heart failure. West J. Nurs. Res. 2005, 27, 977–999. [Google Scholar] [CrossRef]
- Bentley, B.; De Jong, M.J.; Moser, D.K.; Peden, A.R. Factors related to nonadherence to low sodium diet recommendations in heart failure patients. Eur. J. Cardiovasc. Nurs. 2005, 4, 331–336. [Google Scholar] [CrossRef]
- Reilly, C.M.; Higgins, M.; Smith, A.; Culler, S.D.; Dunbar, S.B. Isolating the benefits of fluid restriction in patients with heart failure: A pilot study. Eur. J. Cardiovasc. Nurs. 2015, 14, 495–505. [Google Scholar] [CrossRef]
- Sanches Machado d’Almeida, K.; Ronchi Spillere, S.; Zuchinali, P.; Corrêa Souza, G. Mediterranean diet and other dietary patterns in primary prevention of heart failure and changes in cardiac function markers: A systematic review. Nutrients 2018, 10, 58. [Google Scholar] [CrossRef] [Green Version]
- Cattadori, G.; Segurini, C.; Picozzi, A.; Padeletti, L.; Anzà, C. Exercise and heart failure: An update. ESC Heart Fail. 2018, 5, 222–232. [Google Scholar] [CrossRef]
- Okwose, N.C.; O’Brien, N.; Charman, S.; Cassidy, S.; Brodie, D.; Bailey, K.; MacGowan, G.A.; Jakovljevic, D.G.; Avery, L. Overcoming barriers to engagement and adherence to a home-based physical activity intervention for patients with heart failure: A qualitative focus group study. BMJ Open 2020, 10, e036382. [Google Scholar] [CrossRef]
- Patti, A.; Merlo, L.; Ambrosetti, M.; Sarto, P. Exercise-based cardiac rehabilitation programs in heart failure patients. Heart Fail. Clin. 2021, 17, 263–271. [Google Scholar] [CrossRef]
- Celano, C.M.; Villegas, A.C.; Albanese, A.M.; Gaggin, H.K.; Huffman, J.C. Depression and anxiety in heart failure: A review. Harv. Rev. Psychiatry 2018, 26, 175–184. [Google Scholar] [CrossRef]
- Zhang, Y.; Coats, A.; Zheng, Z.; Adamo, M.; Ambrosio, G.; Anker, S.D.; Butler, J.; Xu, D.; Mao, J.; Khan, M.S.; et al. Management of heart failure patients with COVID-19: A joint position paper of The Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2020, 22, 941–956. [Google Scholar] [CrossRef]
- Ayenigbara, I.O.; Adeleke, O.R.; Ayenigbara, G.O.; Adegboro, J.S.; Olofintuyi, O.O. COVID-19 (SARS-CoV-2) pandemic: Fears, facts and preventive measures. Germs 2020, 10, 218–228. [Google Scholar] [CrossRef]
- Girerd, N.; Chapet, N.; Roubille, C.; Roncalli, J.; Salvat, M.; Mouquet, F.; Lamblin, N.; Gueffet, J.P.; Damy, T.; Galinier, M.; et al. Vaccination for respiratory infections in patients with heart failure. J. Clin. Med. 2021, 10, 4311. [Google Scholar] [CrossRef]
- Barrett, D.; Heale, R. What are Delphi studies? Evid. Based Nurs. 2020, 23, 68–69. [Google Scholar] [CrossRef]
Section | Categories and Subcategories | |
---|---|---|
I. Understanding HF | 1. Definition | |
(1) Anatomy and physiology of the heart, (2) Mechanism of disease | ||
2. Cause and risk factor | ||
(1) Coronary diseases, (2) Cardiomyopathy, (3) Valvular diseases (4) Hypertension, (5) Atrial fibrillation * | ||
3. Signs and symptoms | ||
(1) Main symptoms: (1) dyspnea, (2) increasing body weight, (3) edema, (4) fatigue, (5) cough with sputum, (6) tachycardia, (7) anorexia and indigestion, (8) dizziness and memory loss *, (2) Symptoms of right and left HF, (3) NYHA functional classification (I to IV) | ||
4. Screening and diagnosis | ||
(1) History taking and physical examination, (2) Electrocardiography (3) Chest X-ray, (4) Blood test (including BNP or NT-proBNP), (5) Echocardiography, (6) Cardiac CT *, (7) Cardiac MRI *, (8) Coronary angiography *, (9) Exercise stress test *, (10) Cardiac biopsy *, (11) Genetic testing * | ||
5. Treatment | ||
(1) Medications, (2) Medical and surgical procedures: (1) valve replacement, (2) percutaneous coronary intervention, (3) coronary artery bypass graft, (4) cardiac resynchronization therapy, (5) intracardiac defibrillator, (6) ventricular assist device, (7) heart transplantation | ||
II. Medication treatments of HF | 1. Importance of medication treatments | |
2. Medications for HF in major organs | ||
(1) Heart and coronary artery, (2) Kidney, (3) Blood vessels | ||
3. Type of HF medications | ||
(1) Medication for increasing survival rate: (1) angiotensin-converting enzyme inhibitor, (2) angiotensin receptor blocker, (3) beta blocker, (4) angiotensin receptor-neprilysin inhibitor, (5) mineralocorticoid antagonist, (6) selective If channel blocker, (2) Medication for reliving signs and symptoms: (1) diuretics, (2) cardiotonic, (3) Others: (1) anticoagulant, (2) calcium channel blocker, (3) combination tablets, (4) vasodilator | ||
4. Angiotensin-converting enzyme inhibitor | ||
(1) Mechanism of drug action, (2) Name (generic and trade) | ||
5. Angiotensin receptor blocker | ||
(1) Mechanism of drug action, (2) Name (generic and trade) | ||
6. Beta Blocker | ||
(1) Mechanism of drug action, (2) Name (generic and trade) | ||
7. Angiotensin receptor neprilysin inhibitor | ||
(1) Mechanism of drug action, (2) Name (generic and trade) | ||
8. Mineralocorticoid antagonist | ||
(1) Mechanism of drug action, (2) Name (generic and trade) | ||
9. Selective if channel blocker | ||
(1) Mechanism of drug action, (2) Name (generic and trade) | ||
10. Diuretics | ||
(1) Mechanism of drug action, (2) Name (generic and trade), (3) Adverse action and medication interactions related with potassium ion | ||
11. Cardiotonic | ||
(1) Mechanism of drug action, (2) Name (generic and trade), (3) Adverse action and therapeutic digoxin level | ||
12. Anticoagulant | ||
(1) Mechanism of drug action, (2) Name (generic and trade), (3) Adverse action, therapeutic level, and medication interactions related with Vitamin K | ||
13. Calcium channel blocker | ||
(1) Mechanism of drug action, (2) Name (generic and trade) | ||
14. Combination tablets | ||
(1) Mechanism of drug action, (2) Name (generic and trade) | ||
15. Vasodilator | ||
(1) Mechanism of drug action, (2) Name (generic and trade), (3) Nitroglycerin and use | ||
16. How to take medications | ||
(1) Every day right on time and right methods, (2) Do not stop taking medicines by yourself | ||
17. Identifying patients’ medications | ||
(1) Medication related with HF, (2) Other medications | ||
18. Monitoring side effects of medication treatments | ||
(1) Dizziness, (2) Hyperkalemia, (3) Dry cough related to angiotensin-converting enzyme, (4) Dehydration related with diuretics, (5) Bradycardia related with beta blocker | ||
19. Medication interactions | ||
(1) Other medications: OTC drug, (2) Foods, health functional foods, and health supplements | ||
III. Management of HF | 1. Monitoring signs and symptoms | |
(1) Stable status, (2) Caution status, (3) Emergency status | ||
2. Monitoring blood pressure | ||
(1) Importance of checking BP, (2) How to measure BP, (3) Precaution when measuring BP | ||
3. Monitoring body weight for body fluid | ||
(1) Importance of checking BW, (2) Ideal dry BW | ||
4. Monitoring edema | ||
(1) How to assess edema, (2) How to control edema | ||
5. Monitoring urine volume | ||
(1) Checking urine volume | ||
6. Monitoring blood glucose | ||
7. Restricting fluid intake | ||
(1) How much water fluid is restricted? | ||
8. Restricting sodium intake | ||
(1) How much sodium is restricted? (2) Relation between salt and sodium, (3) Low-salt diet at home and on eating out, (4) Sodium ranking in food | ||
9. Restricting fat and cholesterol | ||
(1) Relation between cardiovascular health and fat/cholesterol, (2) Type of cholesterol and normal range, (3) How to control fat and cholesterol in foods | ||
10. HF patient-tailored diet control | ||
(1) Selecting foods by each food group, (2) Question and answer when difficulty in eating meal, (3) How to read nutrient labeling in processed foods: sodium | ||
11. Exercise for HF | ||
(1) Importance of exercise, (2) Recommended exercise, (3) Cautions for exercising, (4) Stretching before exercise | ||
12. No smoking | ||
(1) Health effects by duration of smoking cessation | ||
13. Reduc or stop drinking | ||
(1) Alcohol effects on the heart, (2) Caloric ranking in alcohol beverage | ||
14. Importance of preventing flu and pneumonia | ||
(1) Hand washing, (2) Wearing mask *, (3) Brushing teeth *, (4) Vaccination | ||
15. Work-life balance in HF | ||
16. Sex and intimacy after HF | ||
17. Checking activities of daily living (K-IADL) * | ||
18. Expression the emotions | ||
(1) Importance of expressing the emotions, (2) Checking the emotions (PHQ-9) | ||
19. Stress management and overcome * | ||
(1) Stress and heart burden *, (2) Physical changes under stress *, (3) How to reduce stress *, (4) Muscle relaxation *, (5) Suitable rest and comfortable clothes, (6) Resting | ||
20. What a primary caregiver should do | ||
(1) Checking if patient takes medications, (2) Observing for patient change signs and symptoms, (3) Assisting in low-salt diet control, (4) Helping with physical activity and exercise, (5) Emotional support, (6) Checking and helping with OPD follow-up * | ||
IV. HF diary | 1. Written oath | |
2. Review of monitoring HF symptoms | ||
(1) Caution condition status, (2) Emergency condition status | ||
3. Daily check | ||
(1) Body weight, (2) Blood pressure and pulse rate, (3) Taking medicines, (4) Restricting fluid intake, (5) Monitoring sodium intake, (6) Urine volume, (7) Exercise, (8) No smoking, (9) Reduce or stop drinking, (10) Mood status, (11) Monitoring signs and symptoms |
Contents | Categories | Second Round | Third Round | ||||
---|---|---|---|---|---|---|---|
M ± SD | CVR | CV | M ± SD | CVR | CV | ||
I. Understanding HF | 1. Definition | 4.50 ± 0.527 | 1 | 0.12 | 4.70 ± 0.483 | 1 | 0.10 |
2. Cause and risk factors | 4.50 ± 0.527 | 1 | 0.12 | 4.70 ± 0.483 | 1 | 0.10 | |
3. Signs and symptoms | 4.50 ± 0.527 | 1 | 0.12 | 4.80 ± 0.422 | 1 | 0.09 | |
4. Screening and diagnosis | 4.40 ± 0.516 | 1 | 0.12 | 4.70 ± 0.483 | 1 | 0.10 | |
5. Treatment | 4.40 ± 0.516 | 1 | 0.12 | 4.70 ± 0.483 | 1 | 0.10 | |
II. Medication treatments of HF | 1. Importance of medication treatments | 4.90 ± 0.316 | 1 | 0.06 | 4.90 ± 0.316 | 1 | 0.06 |
2. Medications for HF in major organ | 4.70 ± 0.483 | 1 | 0.10 | 4.90 ± 0.316 | 1 | 0.06 | |
3. Type of HF medications | 4.70 ± 0.483 | 1 | 0.10 | 4.90 ± 0.316 | 1 | 0.06 | |
4. Angiotensin-converting enzyme inhibitor | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
5. Angiotensin receptor blocker | 4.80 ± 0.422 | 1 | 0.09 | 5.00 ± 0.00 | 1 | 0.00 | |
6. Beta blocker | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
7. Angiotensin receptor neprilysin inhibitor | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
8. Mineralocorticoid antagonist | 4.80 ± 0.422 | 1 | 0.09 | 5.00 ± 0.00 | 1 | 0.00 | |
9. Selective sinus node I(f) channel inhibitor | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
10. Diuretics | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
11. Cardiotonic | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
12. Anticoagulant | 4.60 ± 0.516 | 1 | 0.11 | 4.90 ± 0.316 | 1 | 0.06 | |
13. Calcium channel blocker | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
14. Combination tablets | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
15. Vasodilator | 4.80 ± 0.422 | 1 | 0.09 | 5.00 ± 0.00 | 1 | 0.00 | |
16. How to take medications | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
17. Identifying patients’ medications | 4.90 ± 0.316 | 1 | 0.06 | 4.90 ± 0.316 | 1 | 0.06 | |
18. Monitoring side effects of medication treatments | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
19. Medication interactions | 4.60 ± 0.516 | 1 | 0.11 | 4.80 ± 0.422 | 1 | 0.09 | |
III. Management of HF | 1. Monitoring signs and symptoms | 4.90 ± 0.316 | 1 | 0.06 | 4.90 ± 0.316 | 1 | 0.06 |
2. Monitoring and checking blood pressure | 4.90 ± 0.316 | 1 | 0.06 | 4.90 ± 0.316 | 1 | 0.06 | |
3. Monitoring and checking body weight for body fluid | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
4. Monitoring and assessment of edema | 4.90 ± 0.316 | 1 | 0.06 | 4.90 ± 0.316 | 1 | 0.06 | |
5. Monitoring and checking urine volume | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
6. Monitoring and checking blood glucose | 4.70 ± 0.483 | 1 | 0.10 | 4.70 ± 0.483 | 1 | 0.10 | |
7. Restricting fluid intake | 4.90 ± 0.316 | 1 | 0.06 | 4.90 ± 0.316 | 1 | 0.06 | |
8. Restricting sodium intake: at home, at eating out | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
9. Restricting fat and cholesterol | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
10. HF patient-tailored diet control | 4.70 ± 0.483 | 1 | 0.10 | 4.80 ± 0.422 | 1 | 0.09 | |
11. Exercise for HF | 4.70 ± 0.483 | 1 | 0.10 | 4.90 ± 0.316 | 1 | 0.06 | |
12. No smoking | 4.80 ± 0.422 | 1 | 0.09 | 5.00 ± 0.00 | 1 | 0.00 | |
13. Reduce or stop drinking | 4.80 ± 0.422 | 1 | 0.09 | 5.00 ± 0.00 | 1 | 0.00 | |
14. Importance of preventing flu and pneumonia | 4.90 ± 0.316 | 1 | 0.06 | 4.90 ± 0.316 | 1 | 0.06 | |
15. Working | 4.90 ± 0.316 | 1 | 0.06 | 4.90 ± 0.316 | 1 | 0.06 | |
16. Sex and intimacy | 4.70 ± 0.675 | 0.8 | 0.14 | 4.70 ± 0.675 | 0.8 | 0.14 | |
17. Checking activities of daily living (K-IADL) | 4.90 ± 0.316 | 1 | 0.06 | 4.90 ± 0.316 | 1 | 0.06 | |
18. Expression emotions | 4.80 ± 0.422 | 1 | 0.09 | 4.80 ± 0.422 | 1 | 0.09 | |
19. Stress management | 4.80 ± 0.422 | 1 | 0.09 | 5.00 ± 0.00 | 1 | 0.00 | |
20. What a primary caregiver should do | 4.80 ± 0.422 | 1 | 0.09 | 4.90 ± 0.316 | 1 | 0.06 | |
IV. HF diary | 1. Written oath | 4.70 ± 0.483 | 1 | 0.10 | 4.70 ± 0.483 | 1 | 0.10 |
2. Review of monitoring HF symptoms | 4.80 ± 0.422 | 1 | 0.09 | 5.00 ± 0.00 | 1 | 0.00 | |
3. Daily check for 100 days | 4.80 ± 0.422 | 1 | 0.09 | 5.00 ± 0.00 | 1 | 0.00 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lee, S.-J.; Kim, B.-H. Development of Core Educational Content for Heart Failure Patients in Transition from Hospital to Home Care: A Delphi Study. Int. J. Environ. Res. Public Health 2022, 19, 6550. https://doi.org/10.3390/ijerph19116550
Lee S-J, Kim B-H. Development of Core Educational Content for Heart Failure Patients in Transition from Hospital to Home Care: A Delphi Study. International Journal of Environmental Research and Public Health. 2022; 19(11):6550. https://doi.org/10.3390/ijerph19116550
Chicago/Turabian StyleLee, Seo-Jin, and Bo-Hwan Kim. 2022. "Development of Core Educational Content for Heart Failure Patients in Transition from Hospital to Home Care: A Delphi Study" International Journal of Environmental Research and Public Health 19, no. 11: 6550. https://doi.org/10.3390/ijerph19116550
APA StyleLee, S. -J., & Kim, B. -H. (2022). Development of Core Educational Content for Heart Failure Patients in Transition from Hospital to Home Care: A Delphi Study. International Journal of Environmental Research and Public Health, 19(11), 6550. https://doi.org/10.3390/ijerph19116550